A) Show the structure of the molecule/peptide B) Identify and show the structure of its receptor C) Detail the molecular mechanism by which it is able to propagate its signal within the cell D) Identify key downstream regulatory effectors of this process (i.e. what is the effect or outcome?) E) Which tissues does it primarily affect? F) Provide an example of an agonist and antagonist (could be natural or pharmaceuticals) G) Identify a disease/disorder implicated in misregulation or mutation of the process involving that messenger

A) Show the structure of the molecule/peptide B) Identify and show the structure of its receptor C) Detail the molecular mechanism by which it is able to propagate its signal within the cell D) Identify key downstream regulatory effectors of this process (i.e. what is the effect or outcome?) E) Which tissues does it primarily affect? F) Provide an example of an agonist and antagonist (could be natural or pharmaceuticals) G) Identify a disease/disorder implicated in misregulation or mutation of the process involving that messenger

Biochemistry

9th Edition

ISBN:9781319114671

Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Publisher:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Chapter1: Biochemistry: An Evolving Science

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

Cyclic-AMP stimulates which of the following? a) PKA b) PKC c) Ras d) RTK
The transforming growth factory beta (TGF-b) family of hormones / growth factors are dimers and they interact with specific receptors. Which of the following statements about these receptors is correct? a) A receptor complex is formed from a type 1 and a type 2 receptor b) A receptor complex is formed between the ligand and the receptor c) This family interacts with a single serine- threonine kinase receptor d) The major receptor is intracellular e) The receptor is a G-protein receptor
1) A drug that binds at the same site as the neurotransmitter and prevents the neurotransmitter from opening ion channels would be termed a(n) a) direct antagonist b) direct agonist c) indirect agonist d) indirect antagonist 2) A drug that binds at a site different from that of the neurotransmitter and opens ion channels would be termed a(n) a) direct antagonist b) direct agonist c) indirect agonist d) indirect antagonist
Signaling by tyrosine kinase receptors is generally associated with all of the following except: OA) receptor dimerization B) growth factor responses C) heterotrimeric G proteins OD) cross phosphorylation E) generating protein binding sites due to phosphorylation
The p75 receptor differs from Trk receptors in that it a) can promote cell death. b) has high affinity for all neurotrophins. c) only binds a particular type of neurotrophin. d) can bind NGF to promote cell survival.
Although insulin initially acts through a tyrosine kinase receptor it also subsequently results in activation of a Ser/Thr protein kinase. Which one? A) Protein kinase A B) Protein kinase B C) Protein kinase C D) Ras E) Phosphoinositide-3-kinase
Beta-blockers are used to treat cardiovascular disorders because they are antagonists at beta-adrenergic receptors. Within the cell this activity will be seen as? OA) Increased signaling via the G₁ protein B) Increased protein kinase A activity Decreased phospholipase C activity D) Decreased cAMP levels E) Increased inositol 1,4,5-trisphosphate levels
Signaling by tyrosine kinase receptors is generally associated with all of the following except: A) receptor dimerization B) growth factor responses C) heterotrimeric G proteins D) cross phosphorylation E) generating protein binding sites due to phosphorylation
7. A) What effect does the compound GppNHp, when applied to the inside of a cell during whole cell patch clamp recording, have on Cav2 channels at presynaptic terminals? B) What is the mechanism by which this compound affects G-protein signaling and Ca√2 channel activity? B. A.
1)The concept of saturation is defined as? a) The ability of a receptor to bind only one type or a limited number of structurally related types of chemical messengers. b) The degree to which receptors are occupied by messengers. c) A decrease in the total number of target-cell receptors for a given messenger d) The increased responsiveness of a target cell to a given messenger 2. Phosphodiesterase activity produces one of the following actions a) Breakdown cAMP b) Increases cAMP c) Increases PKC activity d) Increases cytosolic IP3 levels 3. Phospholipase C leads to one of the following? a) Increase in cAMP b) Breakdown of cAMP c) Increase in cytosolic levels of IP3 and DAG d) A decrease in cytosolic Ca++ concentration
1) State whether the property described below is one of electrical synapses, chemical synapses, or both a) Unidirectionalb) Intercellular communicationc) Ionotropic receptorsd) Connected by gap channelse) Quantal release of neurotransmittersf) Regulation of ion transportg) Negligible synaptic delaye) Bidirectionalf) Activation of secondary messengers
which In a rare condition in which the immediate release of neurotransmitter is affected, a mutation in gene would be detected. a) syntaxin b) synaptotagmin c) syanptobrevin d) synuclein dan